Work

Abstract 748: Phase I trial of fractionated-dose 177Lutetium radiolabeled anti-prostate-specific membrane antigen monoclonal antibody J591 (177Lu-J591) in patients with metastatic castration-resistant prostate cancer (metCRPC)

Year: 2012

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2012-748

Authors: Scott T. Tagawa, Shankar Vallabhajosula, Naveed H. Akhtar, Joseph Osborne, Himisha Beltran, Ankeeta Saran, Gina Mileo, Caryn Ecker, Stanley J. Goldsmith, David M. Nanus, Neil H. Bander

Institution: Weill Cornell Medicine

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2058028340

Cites:

Cited by: 1

Related to: 10